RecruitingNCT06626282

Fertility and Ovarian Reserve in Female Childhood Cancer Survivors

PReserving Fertility and Quality of Life IN Belgian Female Paediatric CancEr SurvivorS


Sponsor

Centre Hospitalier Universitaire de Liege

Enrollment

340 participants

Start Date

Oct 9, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Ovarian function impairment affects the quality of life of the survivors of paediatric cancer by impacting fertility, bone quality and mental and cognitive health. The objective of this project is to evaluate the impact of low-intermediate dose alkylating agents associated or not with ovarian cryopreservation technique on ovarian function in female survivors of paediatric cancer. We propose to identify new epigenetic markers in order to predict the risk of premature ovarian insufficiency. The project will be led by a national multi-disciplinary team (paediatric oncologists, gynaecologists, endocrinologists). Paediatric cancer clinical data (therapy, fertility preservation, ...) will be extracted from the Paediatrics Late Effects database and additional data will be collected during PRINCESS fertility evaluation. Through translational and multi-disciplinary approaches, results should improve quality of life and fertility preservation in female survivors of paediatric cancer by developing new personalised screening tools for premature ovarian insufficiency.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study looks at fertility and ovarian health in young women who survived childhood cancer. Researchers want to understand how cancer treatments received during childhood affect reproductive function as these survivors reach adulthood. **You may be eligible if...** - You were diagnosed with cancer between 2004 and 2018 - You were under 17 years old at the time of your cancer diagnosis - You were treated at one of the specified hospitals in Belgium (CHU Liège, CHC, Saint-Luc, or HUDERF) - You are now at least 18 years old - You are alive and in follow-up **You may NOT be eligible if...** - You are a healthy control participant who has had a cancer diagnosis Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(3)

Hopital de la Citadelle

Liège, Wallonia, Belgium

Cliniques Universitaires Saint-Luc

Brussels, Belgium

HUDERF

Brussels, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06626282


Related Trials